Genetic Risk Analysis of Coronary Artery Disease in a Population-based Study in Portugal, Using a Genetic Risk Score of 31 Variants
- PMID: 29972410
- PMCID: PMC6078363
- DOI: 10.5935/abc.20180107
Genetic Risk Analysis of Coronary Artery Disease in a Population-based Study in Portugal, Using a Genetic Risk Score of 31 Variants
Abstract
Background: Genetic risk score can quantify individual's predisposition to coronary artery disease; however, its usefulness as an independent risk predictor remains inconclusive.
Objective: To evaluate the incremental predictive value of a genetic risk score to traditional risk factors associated with coronary disease.
Methods: Thirty-three genetic variants previously associated with coronary disease were analyzed in a case-control population with 2,888 individuals. A multiplicative genetic risk score was calculated and then divided into quartiles, with the 1st quartile as the reference class. Coronary risk was determined by logistic regression analysis. Then, a second logistic regression was performed with traditional risk factors and the last quartile of the genetic risk score. Based on this model, two ROC curves were constructed with and without the genetic score and compared by the Delong test. Statistical significance was considered when p values were less than 0.05.
Results: The last quartile of the multiplicative genetic risk score revealed a significant increase in coronary artery disease risk (OR = 2.588; 95% CI: 2.090-3.204; p < 0.0001). The ROC curve based on traditional risk factors estimated an AUC of 0.72, which increased to 0.74 when the genetic risk score was added, revealing a better fit of the model (p < 0.0001).
Conclusions: In conclusion, a multilocus genetic risk score was associated with an increased risk for coronary disease in our population. The usual model of traditional risk factors can be improved by incorporating genetic data.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Comment in
-
Genetic Risk in Coronary Artery Disease.Arq Bras Cardiol. 2018 Jul;111(1):62-63. doi: 10.5935/abc.20180130. Arq Bras Cardiol. 2018. PMID: 30110045 Free PMC article. No abstract available.
References
-
- Lawrence C, Boerwinkle E. Gene-environment interactions and gene therapy in atherosclerosis. Cardiol Rev. 1994;2:130–137.
-
- Myocardial infarction redefined A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21(18):1502–1513. - PubMed
-
- Abdi H, Williams LJ. Principal component analysis. WIREs Computacional Statistics. 2010;2:433–459.
-
- Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, et al. CHANCES Consortium Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350:h1551–h1551. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
